Home › Chronic Myeloid Leukemia › Tennessee › Nashville
Chronic Myeloid Leukemia clinical trials in Nashville, TN
5 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1089, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Vanderbilt University, Nashville
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
RecruitingPhase 1
- Sarah Cannon Cancer Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RecruitingPhase 1/2
- Tristar BMT, Nashville
HPC Offered for PRESERVE Expansion
RecruitingObservational study
- Tristar Centennial Medical Center, Nashville
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- New York City, NY11 studies
- Seattle, WA11 studies
- Birmingham, AL6 studies
- Portland, OR6 studies
- Philadelphia, PA6 studies
- Baldwin Park, CA6 studies
- Detroit, MI6 studies
- Chicago, IL6 studies
- Durham, NC5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.